Tuesday, March 2, 2021
  • About Us
  • ImagiNATION
  • Adverts
  • Rate Card
  • Contact Us
The Nation Online
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Life & Style
    • Every Woman
      • Soul
      • Family
    • Religion
    • Feature
  • Society
  • Opinion
  • Sports
  • Chichewa
  • Enation
No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Life & Style
    • Every Woman
      • Soul
      • Family
    • Religion
    • Feature
  • Society
  • Opinion
  • Sports
  • Chichewa
  • Enation
No Result
View All Result
No Result
View All Result
Home Society Lifting The Lid On Hiv And Aids

Simplified dosage of HIV medicine for children

by Muza Gondwe
15/08/2020
in Lifting The Lid On Hiv And Aids
2 min read
0
Share on FacebookShare on TwitterShare on WhatsAppShare on LinkedinLinkedinShare via Email

Children living with HIV can now benefit from an adapted, simpler combination therapy. In combination therapy, two or three medicines are used simultaneously to inhibit HIV. One of those agents is dolutegravir. It is now clear that the use of one, widely available, pill of dolutegravir in children yields equally good treatment results as a combination of several, less readily available pills of that drug. Especially in countries where the number of infections is high and good care is less accessible, this makes it easier to treat children. These results are included in the World Health Organisation (WHO) treatment guidelines.

Approximately 1.7 million children worldwide are infected with HIV. However, it is estimated that in 2018, only 56 percent of HIV-infected children had access to proper medication. In addition, the effect in children and teenagers is less desirable than in adults.

RelatedHeadlines

Coronavirus and HIV

Covid-19 and HIV

Are covid-19 vaccines safe for people living with HIV?

It was already known that the drug dolutegravir, in combination with other drugs, is a good treatment for all HIV-infected adults, because it effectively inhibits virus growth and the virus doesn’t quickly develop resistance. Moreover, it is a safe and cheap tool, and widely available: from high to low income countries.

It is also known that treatment options for children often lag behind those for adults. In the case of HIV-inhibiting treatments, children over 12 years of age and 40 kg received the same dose of dolutegravir as adults (one 50 mg pill daily). But younger children, or those of a lower weight, had to take two or more pills a day, but of a lower amount (10mg and 25mg), a dosage not approved by all drug agencies.

This is a problem because these lower dosages are not easily available in most countries. The study focused on simplifying the dosage of dolutegravir that children could take every day. The results show that one 50 mg pill of dolutegravir per day, the same dose as adults, works well in the children and that their body responds to the medicine in the same way as the more difficult dose to give. This benefits the treatment of the children.

As a result of this study, the WHO amended the guidelines for treatment in HIV-positive children.

Previous Post

Hamba Kahle Mayi Dinala

Next Post

Schools to reopen early September—Chakwera

Related Posts

Lifting The Lid On Hiv And Aids

Coronavirus and HIV

January 23, 2021
Lifting The Lid On Hiv And Aids

Covid-19 and HIV

January 9, 2021
Lifting The Lid On Hiv And Aids

Are covid-19 vaccines safe for people living with HIV?

December 26, 2020
Next Post
Chakwera: They have tofollow set guidelines

Schools to reopen early September—Chakwera

Opinions and Columns

My Turn

Tackling global slowdowns

March 1, 2021
People’s Tribunal

Burglary at the hill

February 28, 2021
Search Within

Perseverance landed, is alive and well

February 28, 2021
Emily Mkamanga

Tasting your own salt in politics

February 28, 2021

Trending Stories

  • Olela: We are excited

    K5bn Sunbird Waterfront hotel opens May

    0 shares
    Share 0 Tweet 0
  • Inside Chisale’s seized property

    0 shares
    Share 0 Tweet 0
  • We won’t give Up—Chakwera

    0 shares
    Share 0 Tweet 0
  • Exclusive: RBM’s Mzuzu branch payment mess exposed

    0 shares
    Share 0 Tweet 0
  • Court declares Escom private company

    0 shares
    Share 0 Tweet 0
  • Values
  • Our Philosophy
  • Editorial policy
  • Advertising Policy
  • Code of Conduct
  • Plagiarism disclaimer
  • Disclaimer
  • Privacy Policy
  • Terms of use

© 2021 Nation Publications Limited. All Rights Reserved.

No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Life & Style
    • Every Woman
      • Soul
      • Family
    • Religion
    • Feature
  • Society
  • Opinion
  • Sports
  • Chichewa
  • Enation

© 2020 Nation Publications Limited. All Rights Reserved.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.